Jazz Pharmaceuticals (JAZZ) earnings

Earnings (net income) · fiscal 2025
-$356.15M

Jazz Pharmaceuticals (JAZZ) reported net income of -$356.15M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was $560.12M. Figures as of 18 Nov 2026, 05:04 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
-$356.15M
Highest on record
$560.12Mfiscal 2024
Lowest on record
-$356.15Mfiscal 2025
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Jazz Pharmaceuticals earnings, in more detail

Across the 17 fiscal years on record (2009–2025), the highest was $560.12M in fiscal 2024 and the lowest -$356.15M in fiscal 2025.

History · 17 fiscal years

Earnings (net income) by fiscal year

Jazz Pharmaceuticals earnings, year by year

Jazz Pharmaceuticals (JAZZ) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025-$356.15M 163.6% down
2024$560.12M 35.0% up
2023$414.83M—
2022-$224.06M—
2021-$329.67M 238.2% down
2020$238.62M 54.4% down
2019$523.37M 17.1% up
2018$447.10M 8.4% down
2017$487.85M 22.9% up
2016$396.83M 20.4% up
2015$329.54M 464.4% up
2014$58.39M 73.0% down
2013$216.31M 25.0% down
2012$288.59M 130.9% up
2011$124.98M 281.3% up
2010$32.78M—
2009-$6.84M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Jazz Pharmaceuticals and comparable companies
CompanyEarnings (net income)Fiscal year
Neurocrine Biosciences NBIX$478.60M2025
Ascendis Pharma ASND-€228.03M2025
ICON ICLR$229.34M2025
Jazz Pharmaceuticals JAZZ-$356.15M2025
Solventum SOLV$1.56B2025
BridgeBio Pharma BBIO-$724.93M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on JAZZ

Jazz Pharmaceuticals, figure by figure

Jazz Pharmaceuticals (JAZZ) overview: price, valuation and scorecardAll health care companies by market value

Jazz Pharmaceuticals earnings: questions and answers

What is Jazz Pharmaceuticals's net income?

Jazz Pharmaceuticals (JAZZ) reported net income of -$356.15M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was $560.12M.

What are the highest and lowest net income figures on record for Jazz Pharmaceuticals?

Across the 17 fiscal years on record (2009–2025), the highest was $560.12M in fiscal 2024 and the lowest -$356.15M in fiscal 2025.

How is Jazz Pharmaceuticals's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Jazz Pharmaceuticals (JAZZ) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/JAZZ/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.